ASES study
Phase 2
Completed
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecifiedHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2021/03/031949
- Lead Sponsor
- Tata Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Patients of carcinoma cervix scheduled for intracavitary application
Exclusion Criteria
known coagulation disorders or thrombocytopenia,
known allergy to any of the drugs involved in the study,
visible excoriation/ skin changes over the sacral area.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method